SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharmaceuticals zooms on reporting 33% rise in Q1 consolidated net profit

24 Jul 2019 Evaluate

Torrent Pharmaceuticals is currently trading at Rs. 1527.65, up by 71.80 points or 4.02% from its previous closing of Rs. 1468.60 on the BSE.

The scrip opened at Rs. 1485.05 and has touched a high and low of Rs. 1558.45 and Rs. 1485.05 respectively. So far 54240 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1964.00 on 29-Mar-2019 and a 52 week low of Rs. 1432.00 on 24-Jul-2018.

Last one week high and low of the scrip stood at Rs. 1565.20 and Rs. 1453.00 respectively. The current market cap of the company is Rs. 26159.67 crore.

The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 18.80% and 9.95% respectively.

Torrent Pharmaceuticals has reported results for first quarter ended June 30, 2019.

The company has reported a rise of 82.79% in its net profit at Rs 223 crore for the quarter under review as compared to Rs 122 crore for the same quarter in the previous year. Total income of the company increased by 9.96% at Rs 1,634 crore for Q1FY20 as compared Rs 1,486 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 32.52% in its net profit at Rs 216 crore for the quarter under review as compared to Rs 163 crore for the same quarter in the previous year. Total income of the company increased by 7.53% at Rs 2,042 crore for Q1FY20 as compared Rs 1,899 crore for the corresponding quarter previous year.

Torrent Pharma Share Price

4181.75 2.90 (0.07%)
20-Apr-2026 10:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.75
Dr. Reddys Lab 1235.00
Cipla 1233.60
Zydus Lifesciences 937.25
Lupin 2328.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×